EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Organ‐sparing strategies in patients with MSI / dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making

Martin Duval iD, Antoine Dardenne, Thomas Samaille, Leo Mas iD, Jérémie H Lefèvre, Xavier Dray, Mathilde Wagner, Romain Cohen iD, Thierry André iD

International Journal of Cancer · 01.09.2026 · 159 (5) · 1096-1108

DOI: 10.1002/ijc.70307 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 29.12.2025. Verfasst von Martin Duval und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Service d'Oncologie Médicale, Hôpital Saint Antoine AP-HP, INSERM UMRS 938, Centre de Recherche Saint-Antoine, Equipe Instabilit…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Microsatellite Instability, DNA Mismatch Repair, Clinical Decision-Making. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 113 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deficiency in DNA mismatch repair (dMMR) is a common pathway of carcinogenesis across different tumor types and confers a characteristic microsatellite instability‐high (MSI‐H) molecular phenotype. The MSI‐H/dMMR phenotype may arise from an inherited pathogenic variant in the context of Lynch syndrome and is most frequently observed in endometrial, colorectal, and gastric cancers. MSI‐H/dMMR is a major predictive biomarker for the efficacy of immune‐checkpoint inhibitors (ICIs). Following the approval of ICIs for metastatic disease, these drugs are now being evaluated in localized disease settings. In this review, we provide an overview of current knowledge regarding the use of ICIs as neoadjuvant therapy and as a part of immuno‐ablative, surgery‐sparing strategies, with a focus on Lynch‐related cancers. Finally, we address the diagnosis, monitoring, and prevention challenges raised by these de‐escalation strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal Neoplasms, Hereditary NonpolyposisMicrosatellite InstabilityDNA Mismatch RepairClinical Decision-MakingOrgan Sparing TreatmentsColorectal NeoplasmsHumansImmune Checkpoint InhibitorsNeoadjuvant Therapy

Stichwörter der Autor:innen

Lynch syndromede‐escalationimmune checkpoint inhibitormicrosatellite instabilitymismatch repair

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Sorbonne Université, Service d'Oncologie Médicale, Hôpital Saint Antoine AP-HP, INSERM UMRS 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe Labellisée par la Ligue Nation…
  • Gut, Liver & Microbiome Research (GLIMMER) FHU, Paris, France.
  • Service de Chirurgie Digestive, Hôpital Saint-Antoine AP-HP, Sorbonne Université, Paris, France.
  • Service d'Endoscopie Digestive, Hôpital Saint-Antoine AP-HP, Sorbonne Université, Paris, France.
  • Sorbonne Université, Service d'Imagerie, Hôpital Saint-Antoine, AP-HP, Laboratoire d'Imagerie Biomédicale, UMR 7371, UMR S 1146, Paris, France.

ORCID-Profile: Martin Duval, Leo Mas, Romain Cohen, Thierry André

Zitieren

APA

Duval, M., Dardenne, A., Samaille, T., Mas, L., Lefèvre, J. H., Dray, X., Wagner, M., Cohen, R., & André, T. (2026). Organ‐sparing strategies in patients with MSI / dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making. International Journal of Cancer, 159(5), 1096-1108. https://doi.org/10.1002/ijc.70307

Vancouver

Duval M, Dardenne A, Samaille T, Mas L, Lefèvre JH, Dray X, et al. Organ‐sparing strategies in patients with MSI / dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making. International Journal of Cancer. 2026;159(5):1096-1108. doi:10.1002/ijc.70307

BibTeX
@article{Duval2026,
  author = {Duval, Martin and Dardenne, Antoine and Samaille, Thomas and Mas, Leo and Lefèvre, Jérémie H and Dray, Xavier and Wagner, Mathilde and Cohen, Romain and André, Thierry},
  title = {Organ‐sparing strategies in patients with MSI / dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {159},
  number = {5},
  pages = {1096--1108},
  doi = {10.1002/ijc.70307}
}
Kostenlos starten →